Evidence map›Paper›PMID 35969745›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Serine 408 phosphorylation is a molecular switch that regulates structure and function of the occludin α-helical bundle.

Atul K Srivastava, Bharat Somireddy Venkata, Yan Y Sweat, Heather R Rizzo, Léa Jean-François, Li Zuo, Kathleen W Kurgan, Patrick Moore, Nitesh Shashikanth, Izabela Smok and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Macronutrients as Regulators of Intestinal Epithelial Permeability: Where Do We Stand?Comprehensive reviews in food science and food safety · 2025
    Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Atul K SrivastavaDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0003-2314-8457
Bharat Somireddy VenkataDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
Yan Y SweatLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.
Heather R RizzoLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.
Léa Jean-FrançoisLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.
Li ZuoLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.ORCID 0000-0001-8606-3050
Kathleen W KurganDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-0621-9535
Patrick MooreDepartment of Pathology, The University of Chicago, Chicago, IL 60637.
Nitesh ShashikanthLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.ORCID 0000-0003-4114-8178
Izabela SmokDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0001-7654-9663
Joseph R SachlebenBiomolecular NMR Facility, The University of Chicago, Chicago, IL 60637.
Jerrold R TurnerLaboratory of Mucosal Barrier Pathobiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115.ORCID 0000-0003-0627-9455
Stephen C MeredithDepartment of Pathology, The University of Chicago, Chicago, IL 60637.ORCID 0000-0002-8427-7466
University of Chicago · USBrigham and Women's Hospital · US

Funding

ZO-1-MEDIATED PROTEIN INTERACTIONS: REGULATORS AND INTEGRATORS OF DIVERSE EPITHELIAL FUNCTIONS IN HEALTH AND DISEASER01DK061931 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2001 to 2026
$15.0M
Therapeutic targeting of protein interactions to reverse MLCK1-mediated intestinal barrier loss and ameliorate disease.R01DK068271 · NIDDK · UNIVERSITY OF CHICAGO · PI JERROLD R. TURNER · 2005 to 2026
$11.3M
Defining single-channel paracellular (tight junction) conductances using nanotechnologyR21GM144801 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI TURNER, JERROLD R. · 2023 to 2024
$469k
Human vs. Rodent Amyloid-beta FibrilsR21AG067036 · NIA · UNIVERSITY OF CHICAGO · PI MEREDITH, STEPHEN C. · 2020 to 2020
$446k
NIA NIH HHS R21 AG067036NIDDK NIH HHS R01 DK061931NIDDK NIH HHS R01 DK068271NIGMS NIH HHS R21 GM144801
6 · The paper itself

Abstract

Occludin is a tetramembrane-spanning tight junction protein. The long C-terminal cytoplasmic domain, which represents nearly half of occludin sequence, includes a distal bundle of three α-helices that mediates interactions with other tight junction components. A short unstructured region just proximal to the α-helical bundle is a phosphorylation hotspot within which S408 phosphorylation acts as molecular switch that modifies tight junction protein interactions and barrier function. Here, we used NMR to define the effects of S408 phosphorylation on intramolecular interactions between the unstructured region and the α-helical bundle. S408 pseudophosphorylation affected conformation at hinge sites between the three α-helices. Further studies using paramagnetic relaxation enhancement and microscale thermophoresis indicated that the unstructured region interacts with the α-helical bundle. These interactions between the unstructured domain are enhanced by S408 phosphorylation and allow the unstructured region to obstruct the binding site, thereby reducing affinity of the occludin tail for zonula occludens-1 (ZO-1). Conversely, S408 dephosphorylation attenuates intramolecular interactions, exposes the binding site, and increases the affinity of occludin binding to ZO-1. Consistent with an increase in binding to ZO-1, intravital imaging and fluorescence recovery after photobleaching (FRAP) analyses of transgenic mice demonstrated increased tight junction anchoring of enhanced green fluorescent protein (EGFP)-tagged nonphosphorylatable occludin relative to wild-type EGFP-occludin. Overall, these data define the mechanisms by which S408 phosphorylation modifies occludin tail conformation to regulate tight junction protein interactions and paracellular permeability.

Indexed as

PhosphoproteinsSerineAnimalsMiceOccludinPhosphorylationProtein Conformation, alpha-HelicalTight JunctionsZonula Occludens-1 ProteinOccludinPhosphoproteinsSerineZonula Occludens-1 Proteinbarrierintestinepermeabilitytight junction

Identifiers

PMID35969745
PMCPMC9407527
OpenAlexW4291804502

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.